IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,839,525 | +98428.4% | 301,068 | +3.0% | 0.05% | -10.2% |
| Q4 2022 | $1,867 | -99.9% | 292,165 | +21.0% | 0.06% | -21.3% |
| Q3 2022 | $2,314,000 | -17.7% | 241,494 | -5.2% | 0.08% | -11.8% |
| Q2 2022 | $2,813,000 | -34.5% | 254,812 | -1.1% | 0.08% | -16.7% |
| Q1 2022 | $4,292,000 | -10.7% | 257,776 | +2.4% | 0.10% | +6.2% |
| Q4 2021 | $4,808,000 | -5.3% | 251,850 | +22.4% | 0.10% | -8.6% |
| Q3 2021 | $5,076,000 | -20.9% | 205,834 | -16.5% | 0.10% | -8.7% |
| Q2 2021 | $6,416,000 | -14.2% | 246,582 | +4.4% | 0.12% | -17.3% |
| Q1 2021 | $7,478,000 | -40.1% | 236,184 | -12.3% | 0.14% | -41.4% |
| Q4 2020 | $12,492,000 | +2.3% | 269,229 | -27.4% | 0.24% | -26.9% |
| Q3 2020 | $12,216,000 | +9.5% | 371,068 | -8.7% | 0.32% | +2.2% |
| Q2 2020 | $11,156,000 | -1.8% | 406,401 | +7.1% | 0.32% | -22.1% |
| Q1 2020 | $11,358,000 | -24.3% | 379,418 | -30.0% | 0.41% | +6.5% |
| Q4 2019 | $15,002,000 | +28.1% | 541,976 | -15.8% | 0.38% | +19.7% |
| Q3 2019 | $11,710,000 | -27.4% | 643,415 | -2.2% | 0.32% | -19.8% |
| Q2 2019 | $16,126,000 | +103.9% | 657,651 | -20.9% | 0.40% | +101.0% |
| Q1 2019 | $7,908,000 | – | 831,515 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |